TrialDiabetologia2026

Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.

Dalong Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.